newsfilter
← Latest News
GlobeNewswire·

Medicus Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

PHILADELPHIA, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided, biotech/life sciences company focused on advancing novel and